CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) — Torrance, California

CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) is a clinical research site located in Torrance, California, United States 90504.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Torrance

Browse all research sites in California · View every site in Torrance

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CenExel CNS - Los Alamitos (Collaborative Neuroscience Research)?

CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) conducted?

CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) has 1 clinical trials on record, with 1 currently active. Their work covers Schizophrenia.

Is CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) accredited by Crixeo Clinical Trials?

CenExel CNS - Los Alamitos (Collaborative Neuroscience Research) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CenExel CNS - Los Alamitos (Collaborative Neuroscience Research)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.